News
A well-connected drug company and Laura Loomer wanted Kennedy ally Vinay Prasad gone. Trump chief of staff Susie Wiles got ...
'Mad Money' host Jim Cramer weighs in on stocks including: Sarepta Therapeutics, Webull, Bitmine Immersion, TE Connectivity, ...
Levi & Korsinsky, LLP notifies investors in Sarepta Therapeutics, Inc. ("Sarepta" or the "Company") (NASDAQ: SRPT) of a class action securities lawsuit.
13h
Investor's Business Daily on MSNSarepta Sells Arrowhead Stake To Stretch Its Cash Runway; And One Stock Dives
Arrowhead Pharmaceuticals stock tumbled Thursday after Sarepta Therapeutics liquefied its entire stake in the smaller biotech ...
The milestone payment is partially funded through Sarepta’s Arrowhead stock sale as both companies push forward with ...
Liquidating its stake in Arrowhead helps Sarepta cover a milestone payment and secure what one analyst described as ...
Sarepta will sell back $50 million worth of shares to cover part of a $100 million milestone payment and its remaining shares worth $174 million.
The Trump administration’s decision to cut nearly $500 million in federal support for the development of mRNA vaccines is ...
A handful of drug companies have formed a group to present lawmakers with research on the negative impacts of Medicare drug ...
Sarepta Therapeutics is selling off Arrowhead Pharmaceuticals’ shares to stretch its cash runway, while also inking a share ...
Sarepta Therapeutics sells 9.3M Arrowhead shares for $174M and fulfills a $100M milestone payment. Read more here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results